Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-01-01 @ 6:08 AM
Study NCT ID:
NCT01491893
Status:
COMPLETED
Last Update Posted:
2023-09-28
First Post:
2011-12-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
PVSRIPO for Recurrent Glioblastoma (GBM)
Sponsor:
Istari Oncology, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Pro00031169
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None